Purchases and Sales Made in Q4 2023 in Alpine Immune Sciences, Inc. (ALPN)
This table provides information about the institutional ownership of Alpine Immune Sciences, Inc. (ALPN) during Q4 2023. The information is specifically focused on institutions that hold shares of ALPINE IMMUNE SCIENCES, INC..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Feb 12, 2024
Q4 2023
|
Decheng Capital LLC
Menlo Park, CA |
BUY
|
- |
7.08MNew |
$60.5M - $143M
|
7.08M
$0
|
|
Feb 14, 2024
Q4 2023
|
Ra Capital Management, L.P.
Boston, MA |
BUY
|
- |
4.91MNew |
$41.9M - $99.3M
|
4.91M
$0
|
|
Feb 14, 2024
Q4 2023
|
Lynx1 Capital Management LP
San Juan, PR |
BUY
|
- |
1.41M+ 58.61% |
$12M - $28.5M
|
3.81M
$0
|
|
Feb 09, 2024
Q4 2023
|
Franklin Resources Inc
San Mateo, CA |
BUY
|
- |
1.22MNew |
$10.4M - $24.7M
|
1.22M
$0
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
847K+ 3006.61% |
$7.23M - $17.1M
|
875K
$0
|
|
Feb 14, 2024
Q4 2023
|
State Street Corp
Boston, MA |
BUY
|
- |
784K+ 129.55% |
$6.7M - $15.9M
|
1.39M
$0
|
|
Feb 14, 2024
Q4 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
760K+ 51.52% |
$6.49M - $15.4M
|
2.23M
$0
|
|
Feb 14, 2024
Q4 2023
|
Paradigm Biocapital Advisors LP
New York, NY |
BUY
|
- |
755K+ 31.18% |
$6.45M - $15.3M
|
3.18M
$0
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
719KNew |
$6.14M - $14.5M
|
719K
$0
|
|
Feb 14, 2024
Q4 2023
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
BUY
|
- |
715KNew |
$6.1M - $14.4M
|
715K
$0
|
|
Feb 13, 2024
Q4 2023
|
Black Rock Inc.
New York, NY |
BUY
|
- |
707K+ 30.04% |
$6.03M - $14.3M
|
3.06M
$0
|
|
Feb 13, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
BUY
|
- |
665K+ 1244.12% |
$5.68M - $13.5M
|
719K
$0
|
|
Feb 14, 2024
Q4 2023
|
Cormorant Asset Management, LP
Boston, MA |
BUY
|
- |
650K+ 34.21% |
$5.55M - $13.1M
|
2.55M
$0
|
|
Feb 14, 2024
Q4 2023
|
Great Point Partners LLC
Greenwich, CT |
BUY
|
- |
625K+ 20.29% |
$5.34M - $12.6M
|
3.7M
$0
|
|
Feb 14, 2024
Q4 2023
|
Janus Henderson Group PLC
London, X0 |
BUY
|
- |
583KNew |
$4.98M - $11.8M
|
583K
$0
|
|
Feb 14, 2024
Q4 2023
|
Octagon Capital Advisors LP
New York, NY |
BUY
|
- |
491K+ 65.51% |
$4.2M - $9.93M
|
1.24M
$0
|
|
Feb 14, 2024
Q4 2023
|
Ikarian Capital, LLC
Dallas, TX |
BUY
|
- |
487KNew |
$4.16M - $9.85M
|
487K
$0
|
|
Feb 14, 2024
Q4 2023
|
Candriam S.C.A.
|
BUY
|
- |
470KNew |
$4.01M - $9.5M
|
470K
$0
|
|
Feb 14, 2024
Q4 2023
|
Ally Bridge Group (Ny) LLC
New York, NY |
BUY
|
- |
357KNew |
$3.05M - $7.22M
|
357K
$0
|
|
Feb 14, 2024
Q4 2023
|
Silverarc Capital Management, LLC
|
BUY
|
- |
298KNew |
$2.54M - $6.02M
|
298K
$0
|
|
Feb 14, 2024
Q4 2023
|
Price T Rowe Associates Inc
Baltimore, MD |
BUY
|
- |
291K+ 20.83% |
$2.48M - $5.88M
|
1.69M
$0
|
|
Feb 14, 2024
Q4 2023
|
Commodore Capital LP
New York, NY |
BUY
|
- |
285K+ 21.51% |
$2.43M - $5.76M
|
1.61M
$0
|
|
Feb 14, 2024
Q4 2023
|
D. E. Shaw & Co., Inc.
New York, NY |
BUY
|
- |
247K+ 507.72% |
$2.11M - $4.99M
|
296K
$0
|
|
Feb 12, 2024
Q4 2023
|
Stem Point Capital LP
New York, NY |
BUY
|
- |
246KNew |
$2.1M - $4.98M
|
246K
$0
|
|
Feb 14, 2024
Q4 2023
|
Voloridge Investment Management, LLC
Jupiter, FL |
BUY
|
- |
234KNew |
$2M - $4.73M
|
234K
$0
|
|
Feb 14, 2024
Q4 2023
|
Marshall Wace, LLP
London, X0 |
BUY
|
- |
221KNew |
$1.89M - $4.47M
|
221K
$0
|
|
Feb 14, 2024
Q4 2023
|
Hudson Bay Capital Management LP
Greenwich, CT |
BUY
|
- |
197KNew |
$1.68M - $3.98M
|
197K
$0
|
|
Feb 13, 2024
Q4 2023
|
Qube Research & Technologies LTD
London, X0 |
BUY
|
- |
196K+ 1943.36% |
$1.67M - $3.96M
|
206K
$0
|
|
Feb 14, 2024
Q4 2023
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
188K+ 98.55% |
$1.6M - $3.8M
|
378K
$0
|
|
Feb 14, 2024
Q4 2023
|
Walleye Capital LLC
Plymouth, MN |
BUY
|
- |
180K+ 96.45% |
$1.53M - $3.63M
|
366K
$0
|
|
Feb 14, 2024
Q4 2023
|
Exome Asset Management LLC
New York, NY |
BUY
|
- |
174KNew |
$1.48M - $3.51M
|
174K
$0
|
|
Feb 13, 2024
Q4 2023
|
Eam Investors, LLC
Solana Beach, CA |
BUY
|
- |
163KNew |
$1.39M - $3.29M
|
163K
$0
|
|
Feb 14, 2024
Q4 2023
|
Israel Englander
Millennium Management LLC | New York, Ny
|
BUY
|
- |
157K+ 135.05% |
$1.34M - $3.17M
|
273K
$0
|
|
Feb 14, 2024
Q4 2023
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
BUY
|
- |
145K+ 4.86% |
$1.24M - $2.94M
|
3.13M
$0
|
|
Feb 01, 2024
Q4 2023
|
Jennison Associates LLC
|
BUY
|
- |
141KNew |
$1.2M - $2.85M
|
141K
$0
|
|
Feb 13, 2024
Q4 2023
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
135K+ 21.53% |
$1.16M - $2.74M
|
764K
$0
|
|
Feb 13, 2024
Q4 2023
|
Goldman Sachs Group Inc
New York, NY |
BUY
|
- |
131K+ 197.91% |
$1.12M - $2.66M
|
198K
$0
|
|
Feb 14, 2024
Q4 2023
|
Ensign Peak Advisors, Inc
Salt Lake City, UT |
BUY
|
- |
130KNew |
$1.11M - $2.63M
|
130K
$0
|
|
Feb 14, 2024
Q4 2023
|
Boothbay Fund Management, LLC
New York, NY |
BUY
|
- |
117KNew |
$998K - $2.36M
|
117K
$0
|
|
Feb 14, 2024
Q4 2023
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
BUY
|
- |
112K+ 639.42% |
$956K - $2.26M
|
129K
$0
|
|
Feb 12, 2024
Q4 2023
|
Wellington Management Group LLP
Boston, MA |
BUY
|
- |
110KNew |
$938K - $2.22M
|
110K
$0
|
|
Jan 29, 2024
Q4 2023
|
Bank Of New York Mellon Corp
New York, NY |
BUY
|
- |
102KNew |
$874K - $2.07M
|
102K
$0
|
|
Feb 13, 2024
Q4 2023
|
Jefferies Financial Group Inc.
New York, NY |
BUY
|
- |
100KNew |
$855K - $2.03M
|
100K
$0
|
|
Feb 14, 2024
Q4 2023
|
Laurion Capital Management LP
New York, NY |
BUY
|
- |
97.2KNew |
$830K - $1.97M
|
97.2K
$0
|
|
Feb 13, 2024
Q4 2023
|
Nan Fung Group Holdings LTD
Central, K3 |
BUY
|
- |
81.7K+ 44.8% |
$697K - $1.65M
|
264K
$0
|
|
Feb 13, 2024
Q4 2023
|
Rafferty Asset Management, LLC
New York, NY |
BUY
|
- |
80.2KNew |
$685K - $1.62M
|
80.2K
$0
|
|
Feb 14, 2024
Q4 2023
|
Altium Capital Management LP
New York, NY |
BUY
|
- |
78.7KNew |
$672K - $1.59M
|
78.7K
$0
|
|
Feb 12, 2024
Q4 2023
|
Monashee Investment Management LLC
Boston, MA |
BUY
|
- |
74.8KNew |
$639K - $1.51M
|
74.8K
$0
|
|
Feb 14, 2024
Q4 2023
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
73.9K+ 412.23% |
$631K - $1.49M
|
91.8K
$0
|
|
Feb 15, 2024
Q4 2023
|
Barclays PLC
London, X0 |
BUY
|
- |
71.2K+ 779.87% |
$608K - $1.44M
|
80.3K
$0
|